Development and Manufacturing Services Agreement, dated June 10, 2015, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Therapeutics Ireland DAC (as successor in interest to River Vision Development Corp)

CMC provides bioprocessing services to pharmaceutical and biotechnology companies;

Customer wishes to contract with CMC for the provision of the Services pursuant to one or more Work Statements that may be entered into from time to time during the Term; and

CMC is willing to perform the Services on the terms in this agreement and the Quality Agreement.

DEFINITIONS. Capitalized terms used in the main body of this agreement but not otherwise defined in the main body are defined in Appendix I.

PERFORMANCE OF THE SERVICES

Work Statements. The Services will be described in one or more Work Statements. As of the Effective Date, the parties are entering into Work Statement No. 1 attached as Appendix III. From time to time during the Term, the parties may enter into additional Work Statements for the performance of Services. Each Work Statement will be signed by each party and will be governed by this agreement. In the event of any conflict between this agreement and a Work Statement, this agreement will control unless the Work Statement expressly refers to the Parties’ intent to alter the terms of this agreement with respect to that Work Statement. For clarity, Customer shall have the right at all times to retain third parties other than CMC to provide services similar or identical to the Services provided under this agreement.

Standards. CMC must use commercially reasonable efforts to perform the Services and meet the Timeline. CMC shall perform the Services in a professional and ethical manner and in accordance with the terms of this agreement, the applicable Work Statement, all applicable laws and regulations, including cGMP standards, and, where applicable, the Specification. CMC shall use best efforts to use the skilled personnel (or similarly qualified personnel) that are specifically identified in the Work Statement. If such skilled personnel are unable to perform the Services because they are no longer employees of CMC, CMC shall notify Customer in writing and the parties shall mutually agree on the replacement for such personnel (such agreement not to be unreasonably withheld, delayed or conditioned). Customer shall have the right at any time during the Term to request that any individual dedicated to Customer’s Services as set forth in the Work Statement be replaced with another individual acceptable to Customer. CMC shall consider such request in good faith. The parties will evaluate CMC’s efforts taking into account the Services being dependent on living systems.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Totality of Services. CMC will not perform any Services other than those described in the Work Statement. Due to the nature of the Services, however, changes to the Services may be necessary to achieve the Objective. If changes to the Services are necessary, the parties will promptly meet to negotiate in good faith and agree on those changes in writing and signed by authorized representatives of both parties per Section 15.4. Changes to the Services may affect the Price and Timeline.

Project Team

Each party will name and notify the other party of its representatives who will form the project team and who will be responsible for planning, executing and discussing issues regarding the Services and communicating with the other party (“Project Team”).

The Project Team will schedule meetings at regular intervals for the purpose of communicating updates on the performance of the Services and providing an initial forum for discussing and resolving any issues encountered with the Services. These meetings will be conducted by telephone or, if necessary, by face-to-face meetings. Each party is responsible for its own costs in attending these meetings.

Any decision by the Project Team that amends the Services will not be binding unless it is recorded in writing and signed by authorized representatives of both parties per Section 15.4.

CUSTOMER MATERIALS

Transfer. Customer must deliver and successfully transfer to the CMC Facility and CMC’s personnel the Customer Materials and other information described in the Work Statement by the deadline in the Work Statement. If relevant, that information must include a full description of the Process and all Customer Know-How relevant to the Cell Line, Customer Materials, Drug Substance and Process. All information must be provided in written form. CMC acknowledges that some parts of materials will be in German. No additional fees for translation shall be charged to Customer.

Customer Assistance. Customer must promptly and, shall use commercially reasonable efforts to within [***] Business Days after the request, make available to CMC suitably qualified and skilled employees to assist in the successful transfer of the Customer Know-How, Customer Materials and Process to CMC. Notwithstanding the foregoing, [***]. CMC shall not be responsible for any delays caused by Customer’s agent.

MSDS. At least [***] Business Days before the delivery of the Customer Materials (including, where applicable, the Cell Line) Customer must provide to CMC an accurate written [“Materials and Safety Data Sheet”) “MSDS” for such materials.

Return of Customer Materials. Within [***] days after completion of the Services, Customer must notify CMC whether it wants CMC to return the Customer Materials to Customer or a third party storage facility or if it wants CMC to dispose of the Customer Materials, in each case, at Customer’s expense. If Customer fails to give the notice required by this Section 3.4 within [***] days after the completion of the relevant Services,

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

TIMELINE CHANGES, SPECIFICATION AND CGMP CHANGES

Timeline Changes

The parties may revise the Timeline by mutual agreement; provided, that the revised Timeline is in writing and agreed by the Project Team.

In addition, CMC may revise the Timeline if a Non-Fault Delay occurs, keeping the revised Timeline as close as possible to the Timeline in effect immediately before the Non-Fault Delay. CMC is not liable for failure to meet the Timeline if any Non-Fault Delay contributes to the failure.

Specification and Quantities

Unless otherwise explicitly set forth in the Work Statement, CMC shall manufacture cGMP Product to meet the Specification and cGMP Batches shall be manufactured in compliance with cGMP.

The Specification may be revised by the parties if agreed by the Project Team in writing and signed by both parties. If the parties cannot agree to a revised Specification, the previous agreed on Specification applies.

All quantities of Product are [***]

Changes in cGMP. If there are any material and unforeseen changes in cGMP or manufacturing regulations that have an impact on the Services to the financial detriment of CMC, the parties must in good faith discuss ways to mitigate such additional costs to CMC in any future Work Statements.

MANUFACTURING CAPACITY AND CANCELLATION FEES

Reservations and Scheduling

As of the Effective Date, and at the execution of each Work Statement, CMC will reserve Slots in its cGMP manufacturing suite for those cGMP Batches to be manufactured under the Services according to the then-current Timeline. CMC hereby covenants that during the Term it will not enter into any agreement with any third party that would conflict with its obligations hereunder or would impair CMC’s ability to meet Customer’s requirements for Services and Product as in accordance with the Timeline and as set forth in the Work Statement. Each Work Statement shall set forth the Commencement Date for the manufacture of Batches under such Work Statement. CMC shall have the right to revise the production schedule with respect to a Work Statement provided that such schedule does not advance or delay such Commencement Date by more than [***] days.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

If the Timeline or a Commencement Date is mutually amended and that amendment affects the scheduled Slot for any Batch, CMC will update its manufacturing schedule and reserve a new Slot for each affected Batch as near in time to the existing vacated Slots as CMC’s then-current schedule will permit, taking into account reserved slots under CMC’s existing manufacturing schedule for its whole facility.

CMC will use commercially reasonable efforts to complete the plans for additional capacity of the CMC Facility that have been described to Customer and [***].

Cancellation of cGMP Batches

Customer must pay CMC the cancellation fees stated below if any cGMP Batch or other Batch scheduled for manufacture in CMC’s cGMP facility (e.g., an engineering batch) is delayed, vacated or cancelled as a result of

Customer terminating the Batch, Slot or this agreement except for termination of this agreement under Section 12.2 (“Termination for Default”) where CMC is the “Defaulting Party;”

CMC terminating the Batch, Slot or this agreement pursuant to12.2 (“Termination for Default”) where Customer is the “Defaulting Party”(each, “Cancelled Batch”); or

a Non-Fault Delay (each, “Cancelled Batch”).

Customer must pay the following amounts to CMC for each Cancelled Batch (“Cancellation Fees”), which shall be reduced by [***]% for a [***]:

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

PACKAGING, DELIVERY, STORAGE, EXAMINATION, DEFECTS AND SAMPLES

Packaging. CMC will package all Product and perishable Deliverables to be Delivered per CMC’s applicable packaging SOPs and Regulatory Obligations.

Delivery

CMC will provide Customer with advance notice of the anticipated date of Delivery of Product. Notice will provided at least [***] Business Days before CMC is to Deliver that Product.

Except as stated in Section 6.2.4 or in the Specifications, all Product that CMC manufactures under this agreement will be [***]. Product will be considered “delivered” on the date Product is [***] (“Delivery” or “Delivered”). Customer may arrange collection at any time during normal business hours on Business Days or other times as may be agreed by the parties.

[***] has no obligation to [***].

Data, results, Batch records and Drug History Records will be delivered by mail or electronic mail.

Title and Risk. Title and risk of loss in the Deliverables transfers to Customer on Delivery.

Storage and Transport. If Customer elects to have a shipping company or other agent (“Shipping Company”) collect and transport the Product on Delivery, Customer must

inform CMC of Customer’s designated Shipping Company before the collection of the Product;

coordinate with the Shipping Company for the shipment of the Product; and

ensure that the Product is stored and transported in accordance with the Shipping Guidelines.

Storage. If Customer or Customer’s Shipping Company is unable to collect the Product at the time of Delivery, CMC will store the Product for a period of [***] Business Days after Delivery, at Customer’s request. Storage of the Product at CMC’s premises after Delivery is [***]. If the Product has not been collected by Customer or Customer’s Shipping Company within [***] Business Days after Delivery, CMC will notify Customer in writing. If Customer or Customer’s Shipping Company fails to collect the Product within [***] Business Days after the date of that notice, CMC may, upon written notice to Customer and without any liability to Customer, either, in its sole discretion, dispose of the Product or continue to store the Product at a cost to Customer in the amount stated in Appendix II. If CMC elects to continue to store the Product, then CMC may subsequently dispose of

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Samples. CMC must store samples of all cGMP Product released by CMC’s quality department with a Certificate of Analysis for the period required by applicable Regulatory Obligations, which in the absence of a definitive time period is [***] years from the date of release or Delivery of the applicable Product. After the expiration of the relevant time period, CMC may, without notifying Customer, destroy the samples or otherwise dispose of them in its sole discretion unless Customer contacts CMC in writing pursuant to Section 15.9 before the expiration date, and CMC and Customer then agree to an alternate plan in a written agreement signed by both parties before the expiration of that period.

Examination of Products for Defects

Customer must promptly examine and test the Products for (a) defect and non-conformity with any applicable cGMP standards that the Products are required to meet under this agreement, and (b) in the case of Product manufactured to Specification and released with a Certificate of Analysis, the failure of the Product to meet Specification (a “Defective Product”). Product that is not specified in the Work Statement to meet cGMP cannot be considered Defective Product.

Where any alleged Defective Product is identified, Customer must notify CMC in writing (“Defect Notice”) within [***] Business Days after receipt of the Product. To be effective, a Defect Notice must identify

the Product;

the date of Delivery and collection;

reasonable detail of the Defect, including test results, if any;

where applicable disclosure of the methodology of all analytical tests performed on the Product and the results of those tests;

confirmation that the Products have been stored and transported in accordance with the applicable Shipping Guidelines.

In consultation with CMC, Customer must return samples of the Products that are subject to the Defect Notice in accordance with the Shipping Guidelines to CMC within [***] Business Days after the date of the Defect Notice.

Following receipt of the Defect Notice, CMC must promptly investigate whether the Defective Product is due to CMC’s negligence or failure to comply with its obligations under this agreement and must report to Customer within [***] Business Days after receipt of the samples whether CMC accepts responsibility for the Defective Product.

If Defective Product is not notified to CMC in accordance with the provisions and time limits stipulated in this Section 6.9, the Product will be considered accepted

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Consequences of Defective Product

If Customer and CMC agree that the Product is Defective Product, then CMC will either replace or rework the Defective Product at Customer’s election and at no additional charge to Customer. CMC will undertake those efforts as soon as reasonably practicable and shall not delay such efforts on account of CMC’s other obligations and commercial commitments to third parties.

If there is a dispute regarding whether a Product is a Defective Product (“Disputed Product”), then analysts from both parties must directly communicate to determine that the parties’ respective methods of analysis are the same and are being executed in the same manner. The parties must use good faith efforts for a period of [***] days to resolve whether the Disputed Product is Defective Product.

If the parties cannot resolve their dispute in the manner described above as to whether a Disputed Product is a Defective Product, the parties must require an independent agreed-on laboratory to test the Disputed Product. The costs of the independent laboratory will be [***]. The decision of the independent laboratory must be in writing. The decision will be binding on the parties as to whether the Disputed Product is a Defective Product unless there has been a manifest error, in which case, the parties will revert to the dispute resolution procedure in Section 15.

Rejected Product. Customer must segregate and must not use any Product for any human clinical testing or trials or any other purpose (other than compliance testing pursuant to this Section 6) after it becomes aware of a basis for rejection or a Defect Notice. On a final determination that any Product is Defective Product, Customer must either (a) return all remaining Defective Product to CMC, or (b) destroy all remaining Defective Product, in either case, at CMC’s election and as soon as possible after request by CMC and at CMC’s cost.

Examination and Correction of Non-Manufacturing Deliverables. Customer must promptly examine and test the Deliverables (other than Products) for any non-conformity with any applicable standards that those Deliverables are required to meet under this agreement. Where any alleged non-conformity is identified, Customer must notify CMC in writing

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Exclusive Remedies. The remedies and obligations under Sections 6.9 and 6.10 are Customer’s sole remedy for Defective Products. The remedies and obligations under Sections 6.12 are Customer’s sole remedy for defective or non-conforming Deliverables that are not Products.

PRICE AND PAYMENT TERMS

Amounts. All amounts stated in this agreement are denominated, and must be paid, in Euros. The Price stated in the Work Statement is exclusive of (a) taxes, duties and other fees imposed by any government authority (other than taxes on CMC’s income); (b) external analysis costs; (c) raw materials and (d) shipping and handling. Customer must pay these amounts in addition to the Price. CMC hereby represents that no VAT is applicable under Danish law.

Payment Schedule. Unless a different payment schedule is provided in the Work Statement, CMC will issue invoices for the Price of Stages as follows:

For all Stages other than those described in Section 7.2.2:

For manufacture of cGMP Product:

[***]% of the Price at the time of Order;

Incidental Costs

Raw Materials. The costs for raw materials and handling are described in the Work Statement.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

External Analysis. The costs and handling for external analysis are described in the Work Statement.

Handling Fees. Customer must pay CMC a handling and processing fee for shipments as described in Appendix II, which covers packaging and other costs for preparing Deliverables for shipment.

Other Fees. Customer must pay CMC the other fees as described in Appendix II if relevant.

Payments. Unless otherwise directed by CMC, all invoices must be paid by wire transfer of immediately available funds to the following account:

Late Payments. If any undisputed amount is not paid in full when due under this agreement, CMC may

charge Customer interest at a rate of [***]% per month on the overdue amount on a compounded basis until payment is received, and

suspend the performance of the Services. Where performance is suspended, CMC will have no liability to Customer for the suspension or delay in the Timeline.

Acceptance of Invoices. All invoices will be considered accepted by Customer unless Customer notifies CMC to the contrary within [***] days after delivery of the applicable invoice.

INTELLECTUAL PROPERTY

Pre-Existing Intellectual Property. Each party retains sole ownership of any Intellectual Property owned or controlled by that party as of the Effective Date or before the commencement of the Services (“Pre-Existing IPR”). Nothing in this agreement assigns or transfers ownership of Pre-Existing IPR.

CHEF1 Technology. Notwithstanding anything to the contrary in this agreement, CMC retains sole ownership of all right, title and interest in (a) the CHEF1 Technology; (b) [***]; (c) all Intellectual Property rights in any of (a) or (b); and (d) all improvements or modifications to any of (a), (b) or (c) (collectively, “CHEF1 Property”). The parties hereby acknowledge and agree that performance of the Services hereunder does not contemplate use of any CHEF1 Property. In the event that CMC intends to use any CHEF1 Property in any Services, CMC will obtain written consent from Customer before using CHEF1 Property in the course of performance of the Services. Absent such notification by CMC and acceptance by Customer, if CMC includes any CHEF1 Property in the performance of the Services, CMC hereby grants to Customer an irrevocable, royalty free, fully paid-up, worldwide, non-exclusive, transferable license, with the right to

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Customer’s Grant of License for the Services. Customer hereby grants to CMC and its Affiliates for the Term a non-exclusive, royalty-free, non-sublicensable, non-transferable license under the Customer Intellectual Property Rights solely to the extent required for CMC’s proper performance of the Services. This license terminates automatically on the termination or expiration of this agreement.

Intellectual Property Created in the Course of the Services. As between the parties and subject to Section 8.2, Customer shall own all right, title, and interest to any and all Intellectual Property that CMC and/or its Affiliates first develops, invents, reduces to practice or makes, solely or jointly with Customer or others in the course of performing the Services that is [***] (collectively, “Customer New IP”). CMC hereby assigns to Customer all right, title and interest of CMC in any Customer New IP. CMC shall execute, and shall require its personnel as well as its Affiliates, or other contractors or agents and their personnel involved in the performance of this Agreement to execute, any documents reasonably required to confirm Customer’s ownership of Customer New IP, and any documents required to apply for, maintain and enforce any patent or other right in the Customer New IP. All Intellectual Property other than Customer New IP CMC and its Affiliates first develops, invents, reduces to practice or makes, solely or jointly with Customer or others in the course of performing the Services will be owned by CMC (“CMC IPR”). Customer hereby assigns to CMC all right, title and interest of Customer in any CMC IPR.

License to CMC IPR. Subject to the terms and conditions of this agreement, CMC hereby grants to Customer a non-exclusive, royalty free, sublicensable (through multiple tiers), worldwide license to use CMC Intellectual Property Rights (excluding any CHEF1 Property) owned or controlled by CMC to the extent necessary to use, make, have made, sell, offer to sell and import the Product and use the Cell Line or Process to manufacture or have manufactured Product. However, this license does not include the right to disclose any Confidential Information of CMC or CMC’s Know How to a third party other than pursuant to a confidentiality agreement containing substantially similar terms to those in Section 9 of this agreement. Customer shall be liable for any breach of this agreement by such third party sublicensee. This license automatically terminates if CMC terminates the Term pursuant to Section 12.2.

Right to File for Protection. Each party may file patent protection on any Intellectual Property it owns in accordance with Section 8.1, 8.2 or 8.4, and the other party will promptly on request cooperate at the requesting party’s reasonable expense, with any requests to assist or enable the party’s protection including signing and delivering documents and other information necessary for the valid application and prosecution of any patent.

Party’s Name. Except as otherwise provided in this agreement or required by any applicable law, regulation or order of an administrative agency or court of competent jurisdiction, neither party shall use the name of the other party or of the other party’s Affiliates, directors, officers or employees in any advertising, news release or other publication except that CMC may identify Customer by name as a customer of CMC.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

No Implied Licenses. Except for the licenses expressly granted in this agreement, no rights or licenses are granted by implication, estoppel or otherwise.

CONFIDENTIAL INFORMATION

The Recipient Party must

use the Confidential Information of the Disclosing Party only during the Term of this agreement and only as reasonably necessary to perform its obligations or to exericise its rights under this agreement;

protect the Confidential Information of the Disclosing Party against unauthorized use or disclosure applying standards of care reasonably expected and no less stringent than the standards applied to protection of Recipient Party’s own confidential information of a similar nature; and

not disclose any Confidential Information of the Disclosing Party to any person or entity except to its Permitted Recipients but then only on a need-to-know basis to those Permitted Recipients who are bound by confidentiality restrictions at least as restrictive as this Section 9.

The obligations in Section 9.1 do not apply to information that:

at the time of its disclosure by the Disclosing Party, was available to the public and could be obtained without reference to the Confidential Information by any person with no more than reasonable diligence;

becomes generally available to the public other than by reason of a breach of this agreement or any breaches of confidence by the Recipient Party or its Permitted Recipients;

at the time of disclosure and as evidenced by the Recipient Party’s written records, was lawfully already within its possession; or

is lawfully provided to the receiving Party, without restriction as to confidentiality or use, by a Third Party lawfully entitled to possession of such Confidential Information; or

is independently developed by the Recipient Party without reference to or use of the Confidential Information of the Disclosing Party.

The Recipient Party may disclose certain Confidential Information of the Disclosing Party, without violating the obligations of this agreement, to the extent that disclosure is required by and in compliance with a valid order of a court or other governmental body having jurisdiction, provided that the Recipient Party provides the Disclosing Party with reasonable prior written notice of the disclosure so as to provide the Disclosing Party with reasonable opportunity to obtain relief from the order and thereafter Recipient Party will disclose only the minimum information required to be disclosed in order to comply.

If the Recipient Party or any of its Permitted Recipients becomes aware of any actual or potential unauthorized use or disclosure of the Confidential Information of the Disclosing Party, the Recipient Party must inform the Disclosing Party as soon as reasonably possible after it becomes aware of that actual or potential unauthorized use or disclosure.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Except as otherwise provided in this agreement or otherwise required by law, neither RVDC nor CMC will disclose any terms of this agreement to any third party without the prior written consent of the other party except to its Permitted Recipients but then only on a need-to-know basis to those Permitted Recipients who are bound by confidentiality restrictions as restrictive as this Section 9.

Notwithstanding the foregoing, each Party shall also be permitted to disclose the terms of this Agreement, in each case under appropriate confidentiality provisions at least as protective as those contained in this Agreement, on a need to know basis, to a bona fide potential or future acquirer or assignee, investment banker, investor, licensee, sublicensee, strategic partner or lender.

On the termination of this agreement or at the request of the Disclosing Party, the Recipient Party must promptly return to the Disclosing Party any Confidential Information of the Disclosing Party then in its possession or control except where that Confidential Information is covered under surviving license rights between the parties. However, each party may retain in its legal files a single copy of any document that contains the Disclosing Party’s Confidential Information solely for the purpose of determining the scope of the obligations under this agreement. Neither party is obligated to destroy electronic files securely archived in accordance with its customary data retention policies.

LIMITED WARRANTIES

Customer Warranties. Customer warrants and represents to CMC that:

Customer has all necessary rights to supply to CMC the Customer Materials (including the Cell Line if provided by Customer) and the Customer Intellectual Property Rights, and CMC has and will have the right to use those items for the performance of the Services and manufacture of the Product;

to its knowledge, as of the Effective Date, the Materials and Safety Data Sheet is accurate and complete and the Customer Materials (including the Cell Line if provided by Customer) are free from all contaminants, including virus, bacteria (other than the Cell Line itself) and other vectors, and if handled and used in accordance with the Materials and Safety Data Sheet supplied by Customer will not cause a health hazard or biohazard, and that it will promptly inform CMC of any changes thereto after the date of execution of this agreement;

to its knowledge, as of the Effective Date, the use of the Cell Line solely as provided by Customer, the Customer Materials, the Customer Intellectual Property Rights does not infringe any Intellectual Property rights of any third parties; and

(a) to its knowledge, as of the Effective Date, the Cell Line solely as provided by Customer and Customer Materials are viable, adequate and suitable for the effective performance of the Services and manufacture of the Product according to the Specification, and (b) the information supplied to CMC regarding the Cell Line provided by Customer and Process is accurate and complete.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

CMC Warranties. CMC warrants and represents to Customer that:

it has the necessary permits, facilities, third party contractors and skilled personnel that may be reasonably anticipated to be necessary of a biologics contract manufacturer for the regular provision of manufacturing and development services of biologic material and to provide the Services contemplated hereunder in accordance with the Timeline;

all Deliverables will be Delivered free of financial encumbrances or liens created by CMC but no warranty is given in this Section 10.2.2 as to (a) non-infringement of third party Intellectual Property rights, or (b) freedom to use;

to its knowledge, as of the Effective Date, the CMC Intellectual Property Rights used in the Services do not infringe third party Intellectual Property rights except that no warranty is given to the extent that infringement arises from the combination of CMC Intellectual Property Rights with the Cell Line, Process, Customer Materials or Customer Intellectual Property Rights;

where Stages are to be performed according to cGMP, CMC will apply the appropriate cGMP standards to the performance of those Stages; and

where Product is released with a Certificate of Analysis by CMC, the Product at the time of release will comply with the criteria specified in that Certificate of Analysis.

Disclaimer of All Other Warranties. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EXCEPT FOR THOSE EXPRESS WARRANTIES IN THIS SECTION 10, NEITHER PARTY MAKES OR GIVES ANY OTHER WARRANTIES, EXPRESS OR IMPLIED (WHETHER BY STATUTE, CUSTOM, COURSE OF DEALING OR OTHERWISE) AND EACH PARTY HEREBY DISCLAIMS ALL OTHER EXPRESS OR IMPLIED WARRANTIES, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT AND TITLE.

INDEMNIFICATION

CMC’s Indemnity. Customer must indemnify and defend CMC and its Affiliates and each of their respective directors and officers (“CMC Parties”) against any and all losses, liabilities, damages, costs and expenses (including court costs and reasonable attorneys’ fees and expenses) (“Losses”) that the CMC Parties incur to the extent such Losses arise out of or result from any claim, lawsuit or other action or threat by a third party arising out of:

alleged or actual infringement or misappropriation of any Intellectual Property rights of any third party arising from CMC’s use of the Cell Line solely as provided by Customer, Customer Intellectual Property Rights or Customer Materials;

the administration, use, handling, storage or other disposition of the Product or Drug Substance in any form except to the extent such Losses (i) arise out of or result from a breach by CMC of its warranties hereunder or (ii) solely arise out of or solely result from the use of CMC Intellectual Property Rights or CMC’s Confidential Information;

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

use of any Product that was the subject of a Release for Further Processing in accordance with Section 6.3;

any acts of any third party auditor of Customer; and

any material breach of this agreement by the Customer Parties; and

the gross negligence or willful misconduct on the part of one or more of the Customer Parties in performing any activity contemplated by this agreement.

Customer’s Indemnity. CMC must indemnify and defend Customer and its Affiliates and each of their respective directors and officers (“Customer Parties”) against any and all Losses that the Customer Parties incur to the extent such Losses arise out of or result from any claim, lawsuit or other action or threat by a third party arising out of:

material inaccuracy in a Certificate of Analysis such that the certified Product at the time of Delivery does not meet the Specification when certified to meet it;

failure of CMC to manufacture the Product according to cGMP when the Product is released by CMC at the time of Delivery as a cGMP Product;

any material breach of this agreement by the CMC Parties; and

the gross negligence or willful misconduct on the part of one or more of the CMC Parties in performing any activity contemplated by this agreement; and

actual or alleged infringement or misappropriation of any Intellectual Property rights of any third party to the extent that infringement or misappropriation is due to CMC’s use of the CMC Intellectual Property Rights or CMC’s Confidential Information in the performance of the Services but excluding claims where the use is in combination with the Cell Line solely as provided by Customer, Customer Materials or Customer Intellectual Property Rights.

Indemnification Procedure. The party (“Indemnitee”) that claims indemnification under this Section 11 must:

promptly, and in any event within [***] Business Days of it receiving notice of the Claim, notify the other party (“Indemnitor”) in writing of the Claim; provided, that failure to give that notice will not relieve the Indemnitor of its indemnification and defense obligations except to the extent the failure materially prejudices the ability of the Indemnitor to defend against the Claim;

permit the Indemnitor to control the defense of the Claim; and

have the right (at the Indemnitee’s expense) to participate in the defense of the Claim.

Settlement. The Indemnitor must not settle or consent to an adverse judgment in any Claim indemnified by the Indemnitor that adversely affects the interests of the Indemnitee

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

IP Claims. Each party must promptly (and within [***] Business Days if permissible under applicable law or stock exchange rules) notify the other party of any third party allegation of infringement or misappropriation of any third party Intellectual Property rights due to the handling, storage or use of the Cell Line, Customer Materials, Customer Intellectual Property Rights or CMC Intellectual Property Rights or the manufacture of the Product.

TERM AND TERMINATION

Term. The term of this agreement commences on the Effective Date and terminates on the later of (a) the date that all Stages under all Work Statements have been completed and (b) ten years from the Effective Date, unless sooner terminated in accordance with Section 4.4, 12.2, 12.3, 12.4, 12.5 or 15.1 or extended by mutual written agreement of the parties (“Term”).

Termination for Default. Either party (“Non-Defaulting Party”) may terminate this agreement on notice to the other party (“Defaulting Party”) if

the Defaulting Party fails to pay any amount payable under this agreement within 20 Business Days after the due date;

the Defaulting Party commits a material breach of its obligations under this agreement and fails to remedy it during a period of 30 Business Days starting on the date of receipt of notice from the Non-Defaulting Party identifying the breach and requiring it to be remedied;

a petition is filed against the Defaulting Party for an involuntary proceeding under any applicable bankruptcy or other similar law and that petition has not been dismissed within 60 days after filing or a court having jurisdiction has appointed a receiver, liquidator, trustee or similar official of the Defaulting Party for any substantial portion of its property, or ordered the winding up or liquidation of its affairs; or

the Defaulting Party commences a voluntary proceeding under applicable bankruptcy or other similar law, has made any general assignment for the benefit of creditors, or has failed generally to pay its debts as they become due.

Termination for Convenience

Customer may terminate this agreement or any Stage of the Services at any time before completion of the Services or Stage by giving no less than 30 days’ notice in writing to CMC detailing the Stages of the Services that are to be terminated.

CMC may terminate this agreement at any time after the completion of all Stages under all Work Statements by giving the lesse or (i) 180 days’ written notice to Customer or (ii) such time period as necessary for CMC to complete a technology transfer as set forth in Section 13.2 to Customer or its designee.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Termination for Scientific or Technical Difficulties. CMC may terminate this agreement or any Stage on 60 Business Days’ notice if CMC reasonably concludes that it cannot technically or scientifically deliver the Services contemplated by this agreement or any Stage despite applying its commercially reasonable efforts. During the 60-Business Days’ notice period or when CMC notifies Customer that it has become aware that a technical or scientific problem has or may arise, the parties must in good faith discuss the difficulties and scientific and technical hurdles in an attempt to resolve those problems. If the parties agree during those discussions that the Services can be delivered then the notice to terminate will expire and this agreement (or the Stage as the case may be) will continue in effect. If agreement cannot be reached this agreement or Stage, at CMC’s election, will terminate on expiration of the 60-Business Days’ notice period.

Effect of Termination

Upon termination of this agreement, Customer shall pay to CMC:

with respect to termination for any reason other than for CMC’s material breach under Section 12.2, payments due by Customer to CMC for Services performed up to the effective date of termination for all completed Stages and [***], including any accrued payments owed pursuant to Section 7; and

with respect to termination by Customer pursuant to Section 12.3 or by CMC pursuant to Section 12.2, payments due pursuant to Section 5.2

Upon termination of this agreement for any reason, provided that Customer has paid all undisputed amounts outstanding, CMC will, within [***] Business Days of (a) those payments having been made or (b) the date of termination of this agreement, (whichever is the later) provide the Customer with all Deliverables then manufactured or generated and all transferable work in progress and all Product then manufactured and released, subject to Regulatory Obligations [***].

Survival. Termination will not affect the accrued rights of CMC or Customer arising under this agreement before the effective date of termination and Sections [to come], which will survive in accordance with their terms.

TECHNOLOGY TRANSFER

Scope. Upon termination or during the notice period for termination of this agreement or at any time upon Customer’s reasonable request and at Customer’s reasonable cost, CMC will provide assistance to Customer for the transfer to a single skilled and qualified manufacturer of the then-current Process solely for the purpose of manufacturing Product for Customer, including transfer of documentation, specifications (including raw material specifications) and process validation documents related to the Process or Product (“Technology Transfer”); provided, that [***]. Following CMC’s receipt of that request, the parties will establish a schedule and plan for effecting the transfer and CMC will cooperate with Customer in implementing that plan. As part of the Technology Transfer CMC will make available for collection, subject to any Regulatory Obligations and rights of third parties and Section 12.6.2, all Customer Materials, Cell Line and [***] (to the

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Limits. In the case of termination by CMC, the obligations of CMC under Section 13.1 will only be exercisable by Customer within a period of [***] days after the date of termination and CMC is not obliged to commit any human resources greater than [***] FTE days. In any event of Technology Transfer other than with respect to termination by CMC under Section 12.3.1 or by Customer under Section 12.2, Customer must pay CMC’s costs of cooperating with and providing the Technology Transfer at a daily FTE rate of [***] Euros and all other costs will be charged at cost. Customer will not, and CMC will not be obliged to, transfer any CMC Intellectual Property Rights or CMC IPR pursuant to this Technology Transfer unless the contract manufacturer to whom the Process is transferred is subject to a confidentiality agreement with terms substantially similar to those contained herein in order to protect CMC’s Confidential Information and CMC Intellectual Property Rights.

LIMITATIONS OF LIABILITY

Limitation of Liability. CMC’s aggregate liability to Customer for any loss or damage suffered by Customer as a result of breach of this agreement or any other liability (including negligence, misrepresentation or claims under the indemnities) under this agreement or in connection with the Services is limited, in the aggregate, to the [***].

Disclaimer of Certain Damages. EXCEPT AS PROVIDED IN SECTION 14.3, IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR ANY INCIDENTAL, INDIRECT, PUNITIVE, CONSEQUENTIAL (INCLUDING LOST PROFITS) OR SPECIAL DAMAGES ARISING OUT OF ITS BREACH OF THIS AGREEMENT OR ANY OTHER LIABILITY (INCLUDING NEGLIGENCE, MISREPRESENTATION OR CLAIMS UNDER THE INDEMNITIES) ARISING IN CONNECTION WITH THIS AGREEMENT, EVEN IF THOSE DAMAGES WERE FORESEEABLE AND WHETHER THOSE DAMAGES ARISE IN TORT, IN CONTRACT OR OTHERWISE.

Exclusions. The limitations in Sections 14.1 and 14.2 do not apply to (a) claims arising from either party’s gross negligence or willful misconduct; or (b) liability for any fraud or fraudulent misrepresentation; or (c) claims indemnified by [***].

MISCELLANEOUS

Excused Performance. Neither party will be liable to the other party nor be considered to have breached this agreement for failure or delay in performing (excluding payment of any amounts due under this Agreement) to the extent, and for so long as, the failure or delay is caused by or results from causes beyond the reasonable control of such party. The non-performing party must notify the other party of any force majeure event. If a force majeure event continues for more than 180 day after the non-performing party’s notice, and is adversely affecting the performance of this agreement, each party will have the right terminate this agreement on 30 days’ notice. In that event if CMC is the non-performing party, [***]. Under no circumstances will this Section 15.1 [***]. Customer shall not be liable for cancellation fees [***].

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Insurance. During the Term, CMC must maintain a comprehensive general liability insurance against claims for bodily injury or property damage arising from CMC’s activities in performing the Services, with insurance companies and in amounts [***]. CMC shall provide Customer with a Certificate of Insurance and Policy Amount evidencing general liability coverage within [***] Business Days after the Effective Date. Customer must during the Term and for the longer of (a) [***] years after the termination of this agreement and (b) [***] years after the last use of the Product maintain comprehensive general liability insurance and product liability insurance (including clinical trials coverage) covering all liability and claims arising or that may arise from the use, supply, licensing or distribution of the Product with insurance companies and in amounts [***].

Press Release. Within [***] Business Days after the Effective Date, the parties must agree on a joint press release to announce the collaboration under this agreement. If a joint statement cannot be agreed each party may make their own press release announcing the collaboration between the parties but not disclosing the Product or financial information.

Amendment. Other than as provided for elsewhere in this agreement, any amendment of this agreement (or any document entered into pursuant to this agreement, including Work Statements) will be valid only if it is in writing and signed by each party.

Assignment. Except as provided in this Section 15.5, neither Party may assign its interest under this Agreement without the prior written consent of the other Party, such consent not to be unreasonably withheld; provided, however, that either Party may assign this to an Affiliate of such Party; and provided, further, that either Party may assign this Agreement to a successor in interest by way of merger, acquisition, consolidation or sale of all or substantially all of the business of such Party to which this Agreement relates. Any permitted assignment of this Agreement by either Party will be conditioned upon that Party’s permitted assignee agreeing in writing to comply with all the terms and conditions contained in this Agreement. Any purported assignment without a required consent shall be void. No assignment shall relieve any Party of responsibility for the performance of any obligation that accrued prior to the effective date of such assignment.

Subcontracting. CMC may subcontract to (a) its Affiliates, any of the Services provided that the Affiliate may not further subcontract those Services; (b) Testing Laboratories, only those parts of the Services as explicitly identified in the Work Statement; and (c) any other third party, any of the Services with the prior written consent of Customer (that consent not to be unreasonably withheld, delayed or conditioned). CMC will remain responsible for the activities of its subcontractors except to the extent that Customer requires CMC to use a subcontractor that Customer selects over CMC’s objection.

Waiver. In no event will any delay, failure or omission (in whole or in part) in enforcing, exercising or pursuing any right, power, privilege, claim or remedy conferred by or arising under this agreement or by law, be deemed to be or construed as a waiver of that or any other right, power, privilege, claim or remedy in respect of the circumstances in question, or operate so as to bar the enforcement of that, or any other right, power, privilege, claim or remedy, in any other instance at any time or times subsequently.

Severability. If any provision of this agreement is found by any court or administrative body of competent jurisdiction to be invalid or unenforceable, that invalidity or

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Notices. Any notice or other communication given under this agreement (including under Section 3.4 or 6.6) must be in writing and in English and signed by or on behalf of the party giving it and must be given by hand or by delivering it or sending it by prepaid post or overnight delivery service, to the address and for the attention of the relevant party set out in this Section 15.9 (or as otherwise notified by that party under this Section 15.9). Any notice will be deemed to have been received:

if hand delivered or sent by prepaid overnight delivery service, at the time of delivery; or

if sent by post, five Business Days from the date of posting.

Applicable Law. This agreement will be interpreted and governed, and all rights and obligations of the parties determined, in accordance with the laws of the state of New York (regardless of choice of law provisions to the contrary). The parties waive application of the provisions of the 1980 U.N. Convention on Contracts for the International Sale of Goods, as amended.

Dispute Resolution. Before resorting to litigation, unless emergency relief is required by either party when either party will be free to resort to litigation, the parties must use their reasonable efforts to negotiate in good faith and settle amicably any dispute that may arise out of or relate to this agreement (or its construction, validity or termination) (a “Dispute”). If a Dispute cannot be settled through negotiations by appropriate representatives of each of the parties, either party may give to the other a notice in writing (a “Dispute Notice”). Within [***] days of the Dispute Notice being given the parties must each refer the Dispute to their respective Chief Executive Officers who shall meet in order to attempt to resolve the dispute. If within [***] days of the Dispute Notice (a) the Dispute is not settled by agreement in writing between the parties or (b) the parties have failed to discuss the Dispute or use good faith negotiations, the Dispute may be

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

Relationship of the Parties. Nothing in this agreement operates to create a partnership or joint venture between the parties or authorizes either party to act as agent for the other. Neither party has authority to act in the name of or otherwise to bind the other in any way.

Entire Agreement. This agreement, and the documents referred to in it, constitutes the entire agreement and understanding of the parties and supersedes any previous agreement between the parties relating to the subject matter of this agreement. If any term of this agreement conflicts with any term of the Quality Agreement, the conflicting term of this agreement will prevail. This Agreement is written in English, and the English version of this Agreement will control.

Counterparts. This agreement may be executed in any number of counterparts.

CMC CONFIDENTIAL

FOR DISCUSSION ONLY

/s/ Dave Madden

Dave Madden

CEO

/s/ Gustavo Mahler

Gustavo Mahler

President & COO